Develop a ready-to-use and robust toolbox for Metagenomic applications and evaluate microbiome-based biomarkers of added medical value

Case study
Develop a ready-to-use and robust toolbox for Metagenomic applications and evaluate microbiome-based biomarkers of added medical value

In collaboration with BIOASTER, the industrial partner wanted to better understand the potential of Metagenomics analysis for diagnostic purpose.
Gut microbiota is emerging as new diagnostic and prognostic marker and/or therapeutic target to improve the management of cancer and infectious diseases.
However, methods of sample collection and preparation are not standardized yet. In addition, reliable and ready to use bioinformatics analysis pipeline and advanced softwares are needed for results interpretation by physician end users.
The project aimed at developing and evaluating sample preparation methods and 16S-metagenomic pipeline of analysis and softwares useful for assessing – by NGS – microbiome markers derived from human clinical specimens like stools, blood, urine and broncho-alveolar lavage (BAL).
Another objective of this multifaceted project was to evaluate the diagnostic added value of microbiome biomarkers in some clinical applications.
The outcome of this ambitious project was multiple:
Successful results obtained in this project permitted to the industrial partner to develop a robust and reliable workflow for accurate metagenomics analysis in several diagnostic applications.